Stiff neck, confusion or new weakness, especially alongside fever, need emergency care now. Call 911 or go to an emergency department.
It looks for IgM antibodies, the first antibodies the immune system makes after exposure to West Nile virus, measured in a blood sample (serum) or in cerebrospinal fluid drawn from the lower back. Research suggests that detecting IgM in serum or cerebrospinal fluid is the usual basis for confirming recent West Nile virus infection 1.
Two antibody types matter here. IgM rises early in an infection and then fades over weeks to months. IgG rises later and tends to stay in the blood long term, which makes it a marker of past exposure rather than a current illness. Because IgM is a large molecule that does not pass easily from blood into the fluid around the brain and spinal cord, finding IgM in cerebrospinal fluid points toward infection involving the central nervous system rather than a spillover from the bloodstream 2.
A second kind of test looks for the virus itself, specifically its genetic material, using nucleic acid amplification. Studies indicate that the amount of virus circulating in blood usually falls sharply by the time symptoms appear, so a negative genetic test does not rule the infection out in someone who is already unwell 3.
There is also a confirmatory layer. Specialist laboratories can run a neutralization test, which checks whether a person's antibodies actually block the virus, and this is used to separate true West Nile antibodies from antibodies to closely related viruses 3. Not every case needs that step, but it is why a first result sometimes comes back as presumptive and takes longer to finalize.
Because a small share of infections turn serious, and telling that small share apart from everything else that causes fever in late summer changes what a clinician watches for. Research suggests that most people infected with West Nile virus develop no symptoms at all, roughly one in five develop a febrile illness, and fewer than one percent develop neuroinvasive disease affecting the brain, its lining or the spinal cord 4.
The virus spreads mainly through the bite of an infected mosquito, with birds acting as the reservoir that keeps the cycle going, which is why cases cluster in warm months when mosquitoes are active 4. Less commonly, transmission through transfused blood and transplanted organs has been documented 1.
So testing is not a screening exercise for the general public. Someone with a few days of fever and aches in mosquito season usually recovers without ever learning what the virus was, and that is a reasonable outcome. Testing earns its place when the illness is severe, when neurological signs appear, or when knowing the cause changes the decisions in front of a clinician.
What does a confirmed answer actually buy? It stops a wider search for other causes, it sets expectations for a recovery that can be slow, it tells the care team which complications to monitor for, and it feeds public health surveillance so that local mosquito activity is tracked. None of that is trivial when someone is sick enough to be in hospital.
Fever with headache, body aches, marked fatigue and sometimes a rash during mosquito season raises the question, and new neurological signs push it to the front of the list. The full symptom picture that leads to testing is covered in detail in this guide to west nile virus symptoms.
The mild form tends to look like many other summer viral illnesses, which is exactly the problem. Fever, headache, muscle aches, eye pain, loss of appetite and a flat or bumpy rash on the trunk can all appear, and none of them point specifically at this virus. Fatigue and weakness after the fever settles can outlast the rest of the illness by weeks.
The severe form is different. Neuroinvasive disease is described in three overlapping patterns, meningitis with fever, headache and neck stiffness, encephalitis with confusion, disorientation or reduced consciousness, and acute flaccid paralysis with sudden limb weakness that is often asymmetric and not accompanied by numbness 5. Tremor, trouble with balance and movements that look like a movement disorder have also been described in this setting 5.
The practical rule for a reader is simple. A short febrile illness that is improving day by day rarely needs a West Nile test. Fever with a stiff neck, new confusion, a seizure, or weakness in an arm or leg is an emergency, and testing happens as part of that emergency assessment rather than as something to schedule.
With a standard blood draw, and when the central nervous system is involved, with a lumbar puncture that collects a small amount of spinal fluid. The blood draw is the same as any other venous sample and needs no fasting or special preparation.
A lumbar puncture is done with the person curled on their side or sitting and leaning forward. The skin over the lower back is cleaned and numbed, a thin needle is passed between two vertebrae below where the spinal cord ends, and fluid is collected into several tubes. Pressure inside the spinal canal is often measured at the same time. Afterwards, a headache that is worse when upright is the most common complaint, and the care team will say what to watch for.
Before the tap, the clinician asks about anything that affects clotting. Some medicines matter here, so ask your prescriber rather than stopping anything on your own. A brain scan is sometimes done first in people with certain neurological findings; scan preparations are explained by the team on the day and do not change the antibody test itself.
Samples for West Nile antibodies are frequently sent to a reference or public health laboratory rather than run in the hospital's own lab, and confirmatory work adds further time. Turnaround therefore varies by laboratory and by whether confirmation is needed, so ask the ordering clinician what the current expected wait is rather than planning around a fixed number.
Blood tells you about recent exposure somewhere in the body; spinal fluid tells you whether the central nervous system is involved. They answer different questions, and in a hospital setting both are often sent.
| Sample and test | What it looks for | What a positive result points toward |
|---|---|---|
| IgM antibody test on blood (serum) | Early antibodies against the virus | Infection at some point in recent weeks to months, not always the current illness |
| IgM antibody test on spinal fluid | The same early antibodies, inside the central nervous system | Infection involving the brain, its lining or the spinal cord |
| Nucleic acid test on blood or fluid | Genetic material from the virus itself | Virus present at the moment of sampling; a negative result does not exclude infection |
| Neutralization test at a reference laboratory | Antibodies that specifically block this virus | Confirmation, separating West Nile antibodies from look-alike antibodies to related viruses |
The logic behind the spinal fluid test is the barrier between blood and the nervous system. Antibodies of the IgM class do not cross it readily, so their presence in cerebrospinal fluid is taken as a sign that the immune response is happening inside that compartment 2.
The genetic test has a narrow window of usefulness in symptomatic illness because the virus is often no longer detectable in blood once symptoms start 3. It is more informative in settings where testing happens before symptoms appear, such as screening of donated blood, and in people whose immune systems respond weakly.
After the first several days of symptoms, once the antibody response has had time to develop, and before a positive IgM has aged into something ambiguous. Testing too early can miss antibodies that have not yet risen, and a repeat sample taken later is sometimes needed to settle the question.
The other half of the timing problem is persistence. IgM antibodies against this virus can stay detectable for months after the infection that produced them, so a positive blood IgM in someone who was infected last season may reflect that earlier episode rather than today's fever 6. This is one reason a result is interpreted alongside the symptom timeline, the season and sometimes a second sample showing a rising antibody level.
For a reader, that translates into three practical points. First, a single test taken on day one of a fever may not be the final word. Second, a positive result is read in context rather than in isolation. Third, the clinician may order paired samples spaced apart, and that is normal rather than a sign that something went wrong with the first test.
In the hospital setting none of this delays care. Supportive management begins on clinical grounds, and the test refines the picture rather than gating what happens next.
Cross-reactivity, antibody persistence, the timing of the sample and a weakened immune response, in roughly that order of frequency. Antibody tests detect the shape of the immune response, and several related viruses produce responses that look similar on a screening assay, which is why confirmatory neutralization testing exists at reference laboratories 3.
Past exposure to another virus in the same family, including exposure acquired while travelling, can therefore produce a result that needs a second look. A neutralization test compares how strongly the antibodies block each candidate virus, and that comparison is what sorts it out.
Immune status matters too. In people with weakened immune systems, the antibody response can be delayed or blunted, and research suggests that diagnosis in this group may lean more on detecting viral genetic material rather than antibodies alone 6. A clinician factors that in when choosing which test to send.
Technical factors round out the list. Blood introduced into the spinal fluid sample during a difficult tap can muddy cell counts, and a sample drawn very early in illness may simply predate the antibody rise. None of these make the test unhelpful. They just mean a single number is never read on its own, and that a result described as presumptive is waiting on a further step rather than being wrong.
No. A Total WBCs result cannot confirm or exclude West Nile virus, because the count reflects general immune activity rather than a specific pathogen.
What the white cell count does contribute is context. It is part of the broad picture a clinician builds alongside symptoms, exam findings and, where indicated, spinal fluid results. What the marker measures, how it is tested, how to read a high or low value and what its ranges mean are covered on the Total WBCs biomarker page rather than here.
A complete blood count and a basic metabolic panel are the usual companions, with inflammation markers added in some cases. These do not identify the virus. They describe how the body is coping, including hydration and kidney function in someone who has been feverish and eating little.
| Marker | Typical lab reference range | FitScript optimal range |
|---|---|---|
| Total WBCs | As printed on your lab report | 3.8 to 6 K/µL |
| Marker | Typical lab reference range |
|---|---|
| Creatinine (men) | As printed on your lab report |
| Creatinine (women) | As printed on your lab report |
These are typical lab reference ranges, and they vary by laboratory, age and sex. The FitScript optimal range is an optimization target rather than a diagnostic cut-off, and it is not used to rule an infection in or out. C-reactive protein, a general marker of inflammation, is sometimes added; it can rise with many illnesses and is reported in different units by different labs, so it is interpreted by the ordering clinician rather than against a number quoted here.
This is also where the difference between acute illness testing and health optimization testing becomes clear. FitScript is built around repeat biomarker testing, with 150+ biomarkers tested per year and interpretation from Atlas, FitScript's AI health advisor, to track patterns over time. That kind of panel describes a baseline. It does not replace an acute workup, and an infection suspected today belongs with a clinician who can examine the person.
In neuroinvasive disease, spinal fluid typically shows an increased white cell count with a predominance of lymphocytes, a raised protein level and a glucose level that is usually normal.
Those findings are supportive rather than specific. Many viral infections of the nervous system produce a similar profile, which is why the antibody test on the same sample carries the diagnostic weight. The cell and protein numbers tell the care team that something inflammatory is happening inside the central nervous system; the antibody result suggests what.
The glucose level matters for a different reason. A markedly low spinal fluid glucose alongside a very high neutrophil count shifts attention toward bacterial infection, which is handled as an emergency while results are pending. Clinicians do not wait for a virus result before acting on that possibility.
Fluid pressure measured during the tap and findings on a brain scan add further context, particularly in people with confusion or weakness. Taken together, the picture is read as a whole. Observation, then what it may reflect, then what to do about it, in that order, and the final interpretation belongs to the clinician who has the full chart in front of them.
Several conditions produce fever with headache, neck stiffness or confusion, and the job of testing is to separate the ones that need immediate specific care from the ones managed supportively. Bacterial infection of the lining of the brain is the first thing ruled out, because it moves fast; the warning signs overlap closely with what is described under meningitis symptoms.
Other viral causes of encephalitis sit on the same list, as do other mosquito-borne viruses that circulate in the same season and produce antibodies that can cross-react on screening assays 3. Non-infectious causes of confusion, including metabolic upset and the effects of a severe illness in an older adult, also have to be considered.
Acute flaccid paralysis has its own short differential. Sudden asymmetric limb weakness without sensory loss, in the setting of a febrile illness, is a recognized West Nile pattern 5, but other causes of rapid weakness are assessed in parallel because the management paths differ.
The sequence in practice is usually the same. Immediate assessment and stabilization, spinal fluid collection where it is safe to do so, tests that address the time-critical possibilities first, then the antibody panel that takes longer to return. A reader does not need to run this logic themselves. What they need to know is that fever plus neck stiffness, confusion or new weakness is an emergency department problem, not a next-available-appointment problem.
Adults with symptoms during mosquito season, and particularly older adults and people whose immune systems are suppressed, because severe disease is concentrated in those groups. Advancing age is associated with a higher risk of neuroinvasive disease and of a poorer outcome from it 7.
Immunosuppression, including from conditions and therapies that reduce immune function and from organ transplantation, is also associated with more severe illness and with a diagnosis that may rest more on viral genetic testing than on antibodies 6. Underlying conditions such as diabetes and high blood pressure appear more often among people who develop severe disease 1.
Exposure fills out the picture. Time spent outdoors around dawn and dusk in warm months, mosquito activity in the local area and recent travel to an area with known transmission all raise the pre-test probability enough to make testing sensible when symptoms fit.
What does not justify testing is a mosquito bite alone in someone who feels well. There is nothing useful to measure, a negative result would not change anything, and a positive antibody result found by chance could reflect an infection from a previous season. Prevention, meaning covered skin, repellent used as the label directs, screened windows and removing standing water, does more for a well person than a blood draw does.
The result is matched against the symptom timeline, the exam and the other labs, and then it informs monitoring rather than unlocking a specific medicine. Studies indicate that management is supportive, with no specific antiviral therapy established for this infection 1.
Supportive care means fluids, pain and fever management, monitoring of breathing and swallowing in people with significant weakness, and rehabilitation where function has been affected. Recovery from the mild febrile form is usually complete, although fatigue can linger. After neuroinvasive disease, persistent fatigue, weakness and difficulties with memory or concentration have been described, and recovery from paralysis is often incomplete 5.
A confirmed case is also reportable to public health authorities, which is handled by the laboratory and the clinician. Nothing is required of the person tested beyond the follow-up they are given.
If symptoms overlap with something already being taken, that is a question for the prescriber. Some medicines matter here; ask your prescriber rather than changing anything independently. Any treatment decision, including whether a therapy is appropriate at all, belongs to a licensed provider who has evaluated the person.
An ambiguous or presumptive result is not a failure. It usually means confirmatory work is pending or a second sample is needed, and the clinician will say what the plan is. A result outside the expected pattern is worth discussing with a clinician promptly rather than filing away.
Immediately, by emergency services, if there is fever with a stiff neck, new confusion, a seizure, trouble staying awake, or sudden weakness in an arm or a leg. Those signs need emergency care and are the reason the test exists at all.
Soon, through a regular clinician, if a fever with headache and marked fatigue is not improving after several days in mosquito season, if symptoms return after seeming to settle, or in people whose immune systems are suppressed and who develop any febrile illness. Older adults with a fever and any change in alertness warrant an earlier call rather than a later one.
Routinely, bring it up at a scheduled visit if lingering fatigue or weakness follows a summer illness and is not resolving. That conversation is about function and recovery, and it may or may not involve testing for this particular virus.
This page is educational and is not medical advice. Discuss your symptoms, your results and any treatment with a clinician or licensed provider who can assess you directly.
A clinician orders the test; it is not something you can request off a standard wellness panel. The usual sample is blood, and spinal fluid is collected as well when there are signs that the brain or spinal cord is involved. Samples are often sent to a reference or public health laboratory rather than run on site.
No. A complete blood count and a metabolic panel describe general immune activity, hydration and organ function, not a specific virus. Those results may look entirely normal during the infection. Confirmation requires the specific antibody test on blood or spinal fluid.
Antibodies take several days of illness to become detectable, so a test sent on the first day of symptoms can come back negative even when the infection is present. A clinician may repeat the test on a later sample to settle the question. Testing a well person right after a bite is not useful.
Not necessarily. These antibodies can stay detectable in blood for months after an infection, so a positive result may reflect an earlier episode rather than the current illness. The clinician reads the result against your symptoms, the timing and sometimes a second sample before drawing a conclusion.
Blood answers whether there has been a recent infection somewhere in the body. Spinal fluid answers whether the central nervous system is involved, which changes what the care team monitors. It is collected by lumbar puncture when there is fever with neck stiffness, confusion, seizure or new weakness.
It depends on whether the laboratory runs the test in house or sends it out, and on whether a confirmatory step is needed. Ask the ordering clinician what the current expected wait is at that laboratory. Care does not wait for the result; supportive management starts on clinical grounds.
Care is supportive and focuses on symptoms, hydration, monitoring and, where needed, rehabilitation. A confirmed case is reported to public health by the laboratory or clinician, which requires nothing from you. Any decision about a specific therapy belongs to a licensed provider who has evaluated you.
Generally no. There is nothing informative to measure in someone without symptoms, and an incidental positive antibody result could reflect an older infection. Prevention is the better use of attention: covered skin, repellent used as the label directs, screened windows and no standing water near the home.